Simplex Trading, LLC Lyra Therapeutics, Inc. Transaction History

Simplex Trading, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	$0.13 - $0.22 $124 - $209	954 Added 262.81%	1,317 $0
Q4 2024 Feb 11, 2025	SELL	$0.17 - $0.28 $644 - $1,062	-3,794 Reduced 91.27%	363 $0
Q3 2024 Nov 08, 2024	SELL	$0.24 - $0.34 $29,996 - $42,494	-124,984 Reduced 96.78%	4,157 $1,000
Q2 2024 Jul 25, 2024	BUY	$0.26 - $6.25 $33,576 - $807,131	129,141 New	129,141 $36,000
Q4 2023 Feb 02, 2024	BUY	$2.82 - $5.24 $3,059 - $5,685	1,085 Added 1291.67%	1,169 $6,000

Q3 2023 Nov 01, 2023	SELL	$2.95 - $4.8 $5,047 - $8,212	-1,711 Reduced 95.32%	84 $0
Q2 2023 Aug 04, 2023	BUY	$1.98 - $4.33 $3,554 - $7,772	1,795 New	1,795 $7,000

2.84M

Ticker LYRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,826,400
Market Cap $124M
Description
Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.